Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies

被引:18
作者
Houchi, Selma [1 ]
Messasma, Zakia [2 ,3 ]
机构
[1] Univ Ferhat Abbas Setif 1, Fac Life & Nat Sci, Dept Biochem, Lab Appl Biochem, Setif, Algeria
[2] Univ Ferhat Abbas Setif 1, Fac Technol, Dept Proc Engn, Lab Electrochem Mol Engn & Redox Catalysis, Setif 19000, Algeria
[3] Univ Ferhat Abbas Setif 1, Fac Sci, Dept Chem, Setif 19000, Algeria
关键词
SARS-CoV-2; Delta; Mpro; Spike; Saussurea costus; Saussurea involucrate Molecular docking; IN-VITRO; SESQUITERPENE LACTONE; FLAVONOID COMPOUNDS; AERIAL PARTS; RUTIN; LAPPA; CORONAVIRUS; PLANT; ROOT; HESPERIDIN;
D O I
10.1016/j.molstruc.2022.133032
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The B.1.617.2 Delta variant is considered to be the most infectious of all SARS-CoV2 variants. Here, an attempt has been made through in-silico screening of 55 bioactive compounds from two selected plants, Saussurea costus and Saussurea involucrata as potential inhibitors of two viral proteases, main protease Mpro (PDB ID:6LU7) and the RBD of SGP of Sars-CoV-2 B1.617.2 Delta variant (PDB ID:7ORB) where the binding energy, molecular interactions, ADMET/Tox, chemical descriptors and Quantum-Chemical Calculations were explored. Molecular docking results demonstrated that the three top docked compounds formed relatively stable complexes within the active site and displayed remarkable binding energy in the order of Tangshenoside III, Rutin and Hesperidin (-9.35, -9.14 and -8.57 kcal/mol, respectively) with Mpro and Rutin, Tangshenoside III and Hesperidin (-9.07, -7.71 and -7.57 kcal/mol) with RBD of SGP. These compounds are non-Mutagen and non-carcinogen. Therefore, according to the Lipinski's Rule of Five they exhibited three violations concerning hydrogen acceptor, donor and molecular weight. However, based on the Quantum-Chemical Calculations results the selected ligands have effective reactivity, as they showed lower band gaps . The difference of the E LUMO and E HOMO was low, ranging from 0.0639 to 0.0978 a.u, implying the strong affinity of these inhibitors towards the target proteins. Among the three inhibitors, Rutin exhibited higher reactivity against two viral proteases, main protease (Mpro) and the Sars-CoV-2 B1.617.2, as the band energy gap was lowest among all the three phytochemicals, 0.0639 a.u This could indicate that Rutincan be potential anti-viral drug candidates against the existing SARS-CoV-2, the B.1.617.2 Delta variant.
引用
收藏
页数:19
相关论文
共 130 条
[1]   Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening [J].
Abian, Olga ;
Ortega-Alarcon, David ;
Jimenez-Alesanco, Ana ;
Ceballos-Laita, Laura ;
Vega, Sonia ;
Reyburn, Hugh T. ;
Rizzuti, Bruno ;
Velazquez-Campoy, Adrian .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 164 :1693-1703
[2]   Pharmacological evaluation of anticonvulsant activity of root extract of Saussurea lappa in mice [J].
Ambavade, Shirishkumar D. ;
Mhetre, Nilesh A. ;
Muthal, Amol P. ;
Bodhankar, Subhash L. .
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2009, 1 (03) :131-137
[3]  
[Anonymous], 2013, PLANT LIST VERSION 1
[4]  
[Anonymous], TOPKAT VERSION 6 2
[5]  
Bai Q., 2014, PLOS ONE, V9
[6]  
Baima J.C., 1997, Chin. Pat., Patent No. [CN 1161849A, 1161849, 1161849A]
[7]   The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice [J].
Bao, Linlin ;
Deng, Wei ;
Huang, Baoying ;
Gao, Hong ;
Liu, Jiangning ;
Ren, Lili ;
Wei, Qiang ;
Yu, Pin ;
Xu, Yanfeng ;
Qi, Feifei ;
Qu, Yajin ;
Li, Fengdi ;
Lv, Qi ;
Wang, Wenling ;
Xue, Jing ;
Gong, Shuran ;
Liu, Mingya ;
Wang, Guanpeng ;
Wang, Shunyi ;
Song, Zhiqi ;
Zhao, Linna ;
Liu, Peipei ;
Zhao, Li ;
Ye, Fei ;
Wang, Huijuan ;
Zhou, Weimin ;
Zhu, Na ;
Zhen, Wei ;
Yu, Haisheng ;
Zhang, Xiaojuan ;
Guo, Li ;
Chen, Lan ;
Wang, Conghui ;
Wang, Ying ;
Wang, Xinming ;
Xiao, Yan ;
Sun, Qiangming ;
Liu, Hongqi ;
Zhu, Fanli ;
Ma, Chunxia ;
Yan, Lingmei ;
Yang, Mengli ;
Han, Jun ;
Xu, Wenbo ;
Tan, Wenjie ;
Peng, Xiaozhong ;
Jin, Qi ;
Wu, Guizhen ;
Qin, Chuan .
NATURE, 2020, 583 (7818) :830-+
[8]   Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E [J].
Bonavia, A ;
Zelus, BD ;
Wentworth, DE ;
Talbot, PJ ;
Holmes, KV .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2530-2538
[9]   Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people [J].
Brookman, Sarah ;
Cook, James ;
Zucherman, Mark ;
Broughton, Simon ;
Harman, Katharine ;
Gupta, Atul .
LANCET CHILD & ADOLESCENT HEALTH, 2021, 5 (04) :E9-E10
[10]   Multi-target screening mines hesperidin as a multi-potent inhibitor: Implication in Alzheimer's disease therapeutics [J].
Chakraborty, Sandipan ;
Bandyopadhyay, Jaya ;
Chakraborty, Sourav ;
Basu, Soumalee .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 :810-822